Search

Wan Namkung

from San Francisco, CA
Age ~47
Get Report
Connected to:
Andrew Namkung, 31Dianne L Namkung, 73Janet H Namkung, 35Rosanne B Namm, 72George S Nammack, 92Katherine S Nammacher, 46Richard Namme, 52Norma J Nammensma, 76Krishnakant Nammi, 44David S Nammo, 54

Wan Namkung Phones & Addresses

  • San Francisco, CA

Work

Company: Ucsf Position: Postdoc

Education

School / High School: Yonsei University

Industries

Research

Resumes

Resumes

Wan Namkung Photo 1

Wan Namkung

View page
Location:
30 Medical Center Way, San Francisco, CA
Industry:
Research
Work:
UCSF
Postdoc
Education:
Yonsei University

Publications

Us Patents

Methods Of Treating Diseases With Proanthocyanidin Oligomers Such As Crofelemer

View page
US Patent:
20120202876, Aug 9, 2012
Filed:
Oct 5, 2010
Appl. No.:
13/500589
Inventors:
Alan S. Verkman - San Francisco CA, US
Pravin Chaturvedi - San Francisco CA, US
Wan Namkung - San Francisco CA, US
Assignee:
NAPO PHARMACEUTICALS, INC. - San Francisco CA
REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 31/353
A61P 43/00
A61P 11/00
A61P 21/00
A61P 9/00
A61P 7/00
C12N 5/071
A61P 25/00
US Classification:
514456, 435375
Abstract:
Disclosed herein are methods of treating diseases including gastrointestinal disorders, such as secretory diarrheas, with the proanthocyanidin oligomer, crofelemer. Also disclosed is the anti-secretory effect of crofelemer on Calcium-activated chloride channels (CaCC) and Cystic fibrosis transmembrane conductance regulator (CFTR).

Small Molecule Activators Of Calcium-Activated Chloride Channels And Methods Of Use

View page
US Patent:
20140378510, Dec 25, 2014
Filed:
Aug 3, 2012
Appl. No.:
14/237079
Inventors:
Alan S. Verkman - San Francisco CA, US
Wan Namkung - San Francisco CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
C07D 417/12
C07D 277/46
US Classification:
514342, 514371, 548195, 5462707, 514381, 548251
Abstract:
Provided herein are small molecule activators of calcium-activated chloride channels. These small molecules may be used for treatment of diseases and disorders that are treatable by activating calcium-activated chloride channels, such as cystic fibrosis, disorders related to salivary gland dysfunction (for example, Sjogren's syndrome and dysfunction following radiation injury), dry eye syndrome, and intestinal hypomotility.
Control profile
Wan Namkung from San Francisco, CA, age ~47 Get Report